ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ALGS announcements Aligos Therapeutics Inc announcements and dividends declared NASDAQ

Aligos Therapeutics Inc Complete list of announcements declared & dividend announcements by Aligos Therapeutics Inc ALGS

Aligos Therapeutics Inc ALGS listed on NASDAQ and deals in

Announcements and dividends declared by Aligos Therapeutics Inc ALGS

Aligos Therapeutics, Inc. (ALGS) Reports Q3 Loss, Tops Revenue Estimates
Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of .07 per share versus the Zacks Consensus Estimate of a loss of .15. This compares to loss of .25 per share a year ago. These figures are adjusted for non-re
Announcement as on 06 November 2024

Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Tops Revenue Estimates
Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of [CO].51 per share versus the Zacks Consensus Estimate of a loss of [CO].49. This compares to loss of [CO].89 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 09 March 2023

Aligos Therapeutics raises 0 million as IPO prices at middle of expected range
Aligos Therapeutics Inc.'s initial public offering priced late Thursday at a share, in the middle of the expected range of between and a share. The California-based biopharmaceutical company focused on viral and liver disease treatments sold 1
Announcement as on 16 October 2020

Aligos Therapeutics stock rallies out of the gate, then pulls back
Shares of Aligos Therapeutics Inc. rallied out of the gate Friday, as they opened 16% above the initial public offering price. The stock's first trade on the Nasdaq was at .40 at 1:33 p.m. Eastern for 485,960 shares. The IPO was priced late Thursday at
Announcement as on 16 October 2020

Announcements by Aligos Therapeutics Inc first page |

ALGS Aligos Therapeutics Inc current price & indicator signals

Moving Averages for Aligos Therapeutics Inc

  • 5Day Average: 9.27
  • 12Day Average: 9.2
  • 20Day Average: 9.74
  • 50Day Average: 9.25
  • 100Day Average: 9.65
  • 150Day Average: 9.15
  • 200Day Average: 8.21

ALGS Indicators & signals

Indicator MACD (12,26,9)

9.36, 9.59, -0.12
Indicator MACD is in negative zone

Indicator ADX (14)

2.56, 21.51, 20.43
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ALGS Aligos Therapeutics Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Wed Jan 2026 9.05 8.80 to 9.34 -2.06% 1.28 times
13 Tue Jan 2026 9.24 8.52 to 9.43 6.08% 0.69 times
12 Mon Jan 2026 8.71 8.39 to 9.07 -3.22% 1.61 times
09 Fri Jan 2026 9.00 9.00 to 10.45 -12.88% 1.3 times
08 Thu Jan 2026 10.33 9.61 to 10.49 7.05% 1.3 times
07 Wed Jan 2026 9.65 8.91 to 9.65 10.16% 0.94 times
06 Tue Jan 2026 8.76 8.35 to 8.90 4.16% 0.34 times
05 Mon Jan 2026 8.41 8.25 to 10.00 -7.89% 2.13 times
02 Fri Jan 2026 9.13 9.13 to 9.67 -2.04% 0.27 times
31 Wed Dec 2025 9.32 9.00 to 9.60 2.19% 0.79 times
30 Tue Dec 2025 9.12 9.12 to 9.91 -5.49% 0.63 times
29 Mon Dec 2025 9.65 9.33 to 10.01 -4.55% 0.84 times

Videos related to: ALGS announcements Aligos Therapeutics Inc announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ALGS announcements Aligos Therapeutics Inc announcements and dividends declared NASDAQ

 

Back to top